0001209191-14-075578.txt : 20141215
0001209191-14-075578.hdr.sgml : 20141215
20141215214945
ACCESSION NUMBER: 0001209191-14-075578
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141211
FILED AS OF DATE: 20141215
DATE AS OF CHANGE: 20141215
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LANPHIER EDWARD O II
CENTRAL INDEX KEY: 0001234386
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30171
FILM NUMBER: 141288238
MAIL ADDRESS:
STREET 1: C/O SANGAMO BIOSCIENCES IN STE.A-100
STREET 2: POINT RICHMOND TECH CENTER 501 CANA BLVD
CITY: RICHMOND
STATE: CA
ZIP: 94804
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-12-11
0
0001001233
SANGAMO BIOSCIENCES INC
SGMO
0001234386
LANPHIER EDWARD O II
C/O SANGAMO BIOSCIENCES INC.,
POINT RICHMOND TECH CNTR, 501 CANAL BLVD
RICHMOND
CA
94804
1
1
0
0
President & CEO
Common Stock
2014-12-11
4
A
0
125000
0.00
A
420000
D
Common Stock
2014-12-15
4
F
0
96533
14.7382
D
323467
D
Common Stock
2014-12-15
4
M
0
25000
4.11
A
348467
D
Common Stock
2014-12-15
4
S
0
9000
16.4706
D
339467
D
Common Stock
2014-12-15
4
S
0
16000
14.7923
D
323467
D
Common Stock
1516054
I
By Trust
Employee Stock Option (Right to Buy)
14.07
2014-12-11
4
A
0
250000
0.00
A
2024-12-10
Common Stock
250000
250000
D
Employee Stock Option (Right to Buy)
4.11
2014-12-15
4
M
0
25000
0.00
D
2015-12-11
Common Stock
25000
0
D
Shares subject to restricted stock units ("RSUs"), which will vest in a series of three successive equal annual installments upon the Reporting Person's completion of each year of service over the three year period from the grant date.
Includes 60,000 and 50,000 shares subject to RSUs granted on December 6, 2012 and December 12, 2013, respectively, that will be issued as such units vest in accordance with their terms.
Represents shares withheld to satisfy the Reporting Person's tax withholding obligation upon the vesting and issuance of RSUs.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.41 to $16.56, inclusive. The Reporting Person undertakes to provide to Sangamo BioSciences, Inc., any security holder of Sangamo BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 20, 2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.73 to $15.01, inclusive. The Reporting Person undertakes to provide to Sangamo BioSciences, Inc., any security holder of Sangamo BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
These shares are held in the Edward O. Lanphier II and Cameron M. Lanphier Trust U/T/A August 30, 2002, Edward O. Lanphier II and Cameron M. Lanphier, Trustees.
The stock option vests and becomes exercisable for 25% of the shares upon the Reporting Person's completion of one year of service measured form the grant date, and the balance of the shares will vest and become exercisable in 36 successive equal monthly installments upon his completion of each additional month of service thereafter.
All shares underlying these options are vested and exercisable immediately and such option will expire on December 11, 2015.
/s/ Florence Tam, attorney-in-fact
2014-12-15